Literature DB >> 11357122

Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

K Brejc1, W J van Dijk, R V Klaassen, M Schuurmans, J van Der Oost, A B Smit, T K Sixma.   

Abstract

Pentameric ligand gated ion-channels, or Cys-loop receptors, mediate rapid chemical transmission of signals. This superfamily of allosteric transmembrane proteins includes the nicotinic acetylcholine (nAChR), serotonin 5-HT3, gamma-aminobutyric-acid (GABAA and GABAC) and glycine receptors. Biochemical and electrophysiological information on the prototypic nAChRs is abundant but structural data at atomic resolution have been missing. Here we present the crystal structure of molluscan acetylcholine-binding protein (AChBP), a structural and functional homologue of the amino-terminal ligand-binding domain of an nAChR alpha-subunit. In the AChBP homopentamer, the protomers have an immunoglobulin-like topology. Ligand-binding sites are located at each of five subunit interfaces and contain residues contributed by biochemically determined 'loops' A to F. The subunit interfaces are highly variable within the ion-channel family, whereas the conserved residues stabilize the protomer fold. This AChBP structure is relevant for the development of drugs against, for example, Alzheimer's disease and nicotine addiction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11357122     DOI: 10.1038/35077011

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  573 in total

1.  Experimentally based model of a complex between a snake toxin and the alpha 7 nicotinic receptor.

Authors:  Carole Fruchart-Gaillard; Bernard Gilquin; Stephanie Antil-Delbeke; Nicolas Le Novère; Toru Tamiya; Pierre-Jean Corringer; Jean-Pierre Changeux; André Ménez; Denis Servent
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  Models of the extracellular domain of the nicotinic receptors and of agonist- and Ca2+-binding sites.

Authors:  Nicolas Le Novère; Thomas Grutter; Jean-Pierre Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

3.  Formation of functional alpha3beta4alpha5 human neuronal nicotinic receptors in Xenopus oocytes: a reporter mutation approach.

Authors:  P J Groot-Kormelink; J P Boorman; L G Sivilotti
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

4.  Desensitization of diliganded mouse muscle nicotinic acetylcholine receptor channels.

Authors:  Sergio Elenes; Anthony Auerbach
Journal:  J Physiol       Date:  2002-06-01       Impact factor: 5.182

5.  Identification of regions involved in the binding of alpha-bungarotoxin to the human alpha7 neuronal nicotinic acetylcholine receptor using synthetic peptides.

Authors:  Martha Marinou; Socrates J Tzartos
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

6.  Finite element simulations of acetylcholine diffusion in neuromuscular junctions.

Authors:  Kaihsu Tai; Stephen D Bond; Hugh R MacMillan; Nathan Andrew Baker; Michael Jay Holst; J Andrew McCammon
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

7.  Prediction of 5-HT3 receptor agonist-binding residues using homology modeling.

Authors:  David C Reeves; Muhammed F R Sayed; Pak-Lee Chau; Kerry L Price; Sarah C R Lummis
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

Review 8.  Insights into channel function via channel dysfunction.

Authors:  John F Leite; Nivalda Rodrigues-Pinguet; Henry A Lester
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

9.  Contributions of the non-alpha subunit residues (loop D) to agonist binding and channel gating in the muscle nicotinic acetylcholine receptor.

Authors:  Gustav Akk
Journal:  J Physiol       Date:  2002-11-01       Impact factor: 5.182

Review 10.  Molecular mechanisms of acetylcholine receptor-lipid interactions: from model membranes to human biology.

Authors:  John E Baenziger; Corrie J B daCosta
Journal:  Biophys Rev       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.